ORL - Invento Health Care Group

VIROSTOP nasal sprey

eoranges — Wed, 28 Sep 2022 08:17:18 +0000

VIROSTOP nasal sprey

For the prevention, protection and relief of flu and colds.

“VIROSTOP – for the prevention, protection and relief of flu and colds. A scientific study confirms the inhibitory effect of VIROSTOP spray against infection caused by CORONAVIRUS SARS-CoV-2, as well as other respiratory viruses Influenza A, B. Flu and cold are the most common infectious diseases with respiratory difficulties and significant presence of symptoms. Symptoms appear suddenly and hence the need to react quickly and early. These diseases (including fever) are caused by viruses that are transmitted by droplet infection through the respiratory tract into the body, where they multiply rapidly. Researchers from Herb-pharma AG have developed a unique combination of natural ingredients for VIROSTOP spray, the properties of which make it effective both for prevention and protection against viruses and bacteria. A special extract obtained from Cistus criticalus contains polyphenols in a concentrated form, which create a protective film on the mucous membrane that physically prevents the penetration of bacteria and viruses into the body.

VIROSTOP nasal spray represents a unique combination of natural ingredients for the prevention and protection and relief of flu and cold symptoms, additional treatment of rhinitis and allergic rhinitis and protection of the dried mucous membrane.

A scientific study confirms the inhibitory effect of VIROSTOP nasal spray against infection caused by CORONAVIRUS SARS-CoV-2, as well as other respiratory viruses Influenza A, B.

It is designed to prevent, protect and relieve the symptoms of flu and colds.

VIROSTOP nasal spray covers the mucous membrane of the nasal cavity with a protective layer, thus preventing the penetration of bacteria and viruses into the body. Actively cleans the nasal cavity, moisturizes the nasal mucosa and thus prevents its drying. It helps restore the function of the nasal mucosa and improves breathing through the nose.

Start using Virostop spray immediately after the first signs of a cold/sore throat, sneezing, before the disease develops. Also use if you are at risk of infection

INSTRUCTION FOR USE AND DOSAGE

Shake the spray before use
– remove the protective transparent cap from the applicator
– hold the bottle upright and press the nozzle several times until the spray dose is uniform
– bring the nozzle to the nostril and press the pump, inhale gently through the nose
– after each use, clean the nozzle and put the protective transparent cap back

DOSAGE

Preventive – Adults: 1 dose in each nostril 3-4 times during the day; Children older than 3 years 1 dose in each nostril 2 times a day.
In case of active infection – Adults: 1 dose in each nostril 4-5 times during the day; Children older than 3 years 1 dose in each nostril 3 times a day

ADVERSE EFFECTS

Use is recommended for adults and children older than 3 years.
Pregnant and breastfeeding women should consult their doctor before the use.
Older children can only use the product under adult supervision.
Do not use the product in case of allergies or hypersensitivity to any of the ingredients.
It is not recommended to use the product for several people at the same time, due to the increased risk of transmission of infection.
You may experience a temporary tingling sensation on your tongue during use. This feeling is temporary and natural.

The post VIROSTOP nasal sprey first appeared on Invento Health Care Group.

VIROSTOP oral spray

eoranges — Wed, 28 Sep 2022 08:13:12 +0000

VIROSTOP oral spray

For the prevention, protection and relief of flu and colds.

A scientific study confirms the inhibitory effect of VIROSTOP spray against infection caused by CORONAVIRUS SARS-CoV-2, as well as other respiratory viruses Influenza A, B. Flu and cold are the most common infectious diseases with respiratory difficulties and significant presence of symptoms. Symptoms appear suddenly and hence the need to react quickly and early. These diseases (including fever) are caused by viruses that are transmitted by droplet infection through the respiratory tract into the body, where they multiply rapidly. Researchers from Herb-pharma AG have developed a unique combination of natural ingredients for VIROSTOP spray, the properties of which make it effective both for prevention and protection against viruses and bacteria. A special extract obtained from Cistus criticalus contains polyphenols in a concentrated form, which create a protective film on the mucous membrane that physically prevents the penetration of bacteria and viruses into the body.

VIROSTOP spray represents a unique combination of natural ingredients for the prevention and protection and relief of flu and cold symptoms. A scientific study confirms the inhibitory effect of VIROSTOP spray against infection caused by CORONAVIRUS SARS-CoV-2, as well as other respiratory viruses Influenza A, B. VIROSTOP oral spray covers the mucous membrane of the oral cavity with a protective layer, thus preventing the penetration of bacteria and viruses into the body. Start using Virostop spray immediately after the first signs of a cold/sore throat, sneezing, before the disease develops. use if you are at risk of infection. The spray form allows for easy and even application on the mucous membrane.

INSTRUCTION FOR USE AND DOSAGE

shake the spray before use
– remove the protective transparent cap from the applicator
– hold the spray bottle upright and press the head of the bottle several times until the spray dose is uniform
– bring the applicator to your mouth and apply the required dose

DOSAGE

Preventive – Adults: 1 daily dose for adults 2-5 sprays; Children older than 3 years, 2 sprays in the throat 2 times.
In case of active infection – Adults: 3 sprays 5 times a day; Children older than 3 years 3 pushes 2 times a day

ADVERSE EFFECTS

Use is recommended for adults and children older than 3 years.
Pregnant and breastfeeding women should consult their doctor before the use.
Older children can only use the product under adult supervision.
Do not use the product in case of allergies or hypersensitivity to any of the ingredients.
It is not recommended to use the product for several people at the same time, due to the increased risk of transmission of infection.
You may experience a temporary tingling sensation on your tongue during use. This feeling is temporary and natural.

The post VIROSTOP oral spray first appeared on Invento Health Care Group.

Seratrix

eoranges — Sun, 07 Mar 2021 07:26:55 +0000

STRONG, STRONGER, THE STRONGEST…

SERATRIX®

Gastro-resistant capsules

Combination of proteolytic enzymes
Serapeptase 250,000 SPU Trypsin 335,000 IU Chymotrypsin 65,000 IU

SERATIOPEPTIDASE DECOMPOSES TOXINS AND PROTEIN REMAINS ASSOCIATED WITH INFLAMMATION, INCLUDING THE ABILITY TO BREAKDOWN NON-LIVING TISSUE, DOES NOT USE HEALTHY CELLS AS A SUBSTRATE.

• ANTI-INFLAMMATORY EFFECT The anti-inflammatory activity of seratiopeptidase is attributed to the hydrolysis of inflammatory mediators such as bradykinin, histamine and serotonin. Proteolytic activity on the cell surface leads to changes in the adhesion of molecules that direct inflammatory cells to their targets.
• ANTI-EDEMATOUS EFFECT Dilutes fluid caused by inflammation and injury, allowing it to be eliminated faster, dissolves dead tissue around the wound, improves microcirculation at the site of injury and leads to an acceleration of the repair process of damaged tissue.
• FIBRINOLYTIC EFFECT Breaks down fibrin, an insoluble protein by-product of blood coagulation.
• ANALGESIC EFFECT Relieves pain by preventing the release of pain-causing amines, such as bradykinin. It hydrolyzes inflammatory mediators, which reduces swelling and improves microcirculation, thereby reducing pain caused by pressure on nerve endings at the site of inflammation.
• EFFECT ON BIOFILM Serratiopeptidase exhibits the property of modifying adhesion molecules and thus reduces proteins on the cell surface. Serratiopeptidase modulates adhesion expression in some bacterial species and enhances the efficacy of AB against Biofilm-forming bacteria.

CHYMOTRYPSIN, A PROTEOLYTIC ENZYME, CUTS PROTEINS AT PLACES ALONG THE PROTEIN CHAIN THAT CONTAIN VERY LARGE AMINO ACIDS SUCH AS PHENYLALANNINE, TYROSINE AND TRYPTOPHANE.

It helps reduce redness and swelling caused by surgery or infection and helps heal wounds/traumatic tissue injuries faster. Its anti-inflammatory, antioxidant and anti-infective properties help to resolve the inflammation caused by the injury and help to facilitate the healing process. Trypsin and chymotrypsin are proteolytic enzymes that remove swelling by exerting a proteolytic effect on wounds, hematoma and pain, promote phagocytosis to remove cellular debris and accelerates recovery. They help relieve severe pain and swelling in postoperative wounds and other inflammatory diseases.

TRYPSIN IS ONE OF THE MOST IMPORTANT EXOGENOUS PROTEIN HYDROLASES AND CAME INTO CLINICAL USE IN THE 1960’S. TRYPSIN IS AN ENDOPEPTIDASE THAT SELECTIVELY HYDROLYZES PEPTIDE CHAINS ON ARGININE AND LYSINE RESIDUES, WHICH ARE CREATED IN AN INFLAMMATORY RESPONSE. EXOGENEOUSLY INJECTED TRIPSIN ACCELERATES WOUND HEALING BY WEAKENING THE INFLAMMATORY REACTION, REDUCING EDEMA AND PROTECTING AGAINST INFECTION.

Reduces the effects of pro-inflammatory cytokines such as IL-1, TNF-a and IFN-g in tissues under inflammation Restarts the fibrinolytic process in inflamed and injured tissues, the fibrin barrier is broken, promoting the absorption of fibrin exudate Helps restore local microcirculation, remove inflammatory edema and promoting tissue regeneration. Trypsin also acts on macrophages. Exogenous application of trypsin may therefore have anti-infective properties, by inducing enhanced phagocytic activity of macrophages, thereby enhancing phagocytosis at the site of infectious inflammation. Trypsin plays a role in promoting wound healing by regulating fibroblast differentiation.

SERATRIX® is widely used in many fields of medicine:

Orthopedics: traumatic swelling after sports injuries, fractures, sprains, lacerations, osteoarticular infection at the site of AB application, reduction of joint edema and soft tissue damage and improvement of postoperative recovery speed.
Surgery: traumatic and postoperative inflammation, treatment of active inflammatory edema associated with post-surgical wounds, treatment of traumatic hematomas, ulcers and fistulas, venous inflammatory disease
Gynecology: fibrocystic breast diseases, hysterectomy, PID, episiotomy, caesarean section.
Pulmonology: bronchitis, inadequate expectoration of sputum in bronchial asthma, after anesthesia
Urology: postoperative inflammation, BHP, cystitis, epididymitis
ENT: sinusitis, rhinitis, laryngitis, tonsillitis
Rheumatology: rheumatoid arthritis, osteoarthritis
Dentistry: anti-inflammatory after interventions, surgery, periodontitis, to increase the concentration of antibiotics at the site of infection

Gastro-resistant capsules – without dissolution and loss of activity in an acidic environment

Dosage – 1 capsule once a day, for adults only.

Warnings – do not use two weeks before surgery. Consultation with a doctor and pharmacist for people with ulcers, GI lesions and on anticoagulant therapy

Effect: Anti-inflammatory, anti-edematous, analgesic, mucolytic, fibrinolytic, effect on biofilm

*Teller, P.; White, T.K. The Physiology of Wound Healing: Injury Through Maturation. Perioper. Nurs. Clin. 2011, 6, 159–170
**Strodtbeck, F. Physiology of wound healing. Newborn Infant Nurs. Rev. 2001, 1, 43–52.
***Hogan, S.; Zapotoczna, M.; Stevens, N.; Humphreys, H.; O’Gara, J.; O’Neill, E. Potential use of targeted enzymatic agents in the treatment of Staphylococcus aureus biofilm-related infections. J. Hosp. Infect. 2017, 96, 177–182.
****Mecikoglu, M.; Saygi, B.; Yildirim, Y.; Karadag-Saygi, E.; Ramadan, S.S.; Esemenli, T. The effect of proteolytic enzyme serratiopep-tidase in the treatment of experimental implant-related infection. JBJS. 2006, 88, 1208–1214.
****Selan, L.; Papa, R.; Tilotta, M.; Vrenna, G.; Carpentieri, A.; Amoresano, A.; Pucci, P.; Artini, M. Serratiopeptidase: A well-known metallo-protease with a new non-proteolytic activity against S. aureus biofilm. BMC Microbiol. 2015, 15, 207.

Registration number: 515-02-01885-23-003 from August 25, 2023

More informations

The post Seratrix first appeared on Invento Health Care Group.